Moccasin Envenomation Treatment & Management
- Author: Sean P Bush, MD, FACEP; Chief Editor: Rick Kulkarni, MD more...
Prehospital Care
Do nothing to injure the patient or impede travel to the ED.
Support the airway, breathing, and circulation per advanced cardiac life support (ACLS) protocol with oxygen, monitors, large-bore intravenous lines, and fluid challenge. Minimize activity (if possible), remove jewelry or tight-fitting clothes in anticipation of swelling, and transport the patient to the ED as quickly and as safely as possible. Every 15 minutes, use a pen to mark and time the border of advancing edema.
In recent studies, no benefit was demonstrated when a negative pressure venom extraction device (eg, The Extractor from Sawyer Products) was evaluated; additional injury can result.[8, 9] Incision across fang marks is not recommended. Mouth suction is contraindicated.
Lymphatic constriction bands and pressure immobilization techniques may inhibit the spread of venom, but whether they improve outcome is not clear. These techniques may actually be deleterious for pit viper envenomation if they increase local necrosis or compartment pressure. Tourniquets are not recommended.
Maintain the limb in a neutral position.
First aid that lacks therapeutic value or is potentially more harmful than the snakebite includes electric shock, alcohol, stimulants, aspirin, ice application, and various folk and herbal remedies.[10, 11]
Cost and risk of acute adverse reactions generally preclude field use of antivenom.[10]
Attempts to capture or kill the snake are not recommended because of the risk of additional injury.
In the United States, all pit viper (rattlesnake, pygmy rattlesnake, and moccasin) envenomations are treated similarly, based on the severity of presenting signs and symptoms. Therefore, if the patient shows signs of envenomation (eg, pain, swelling), then species identification is not necessary. The exception to this rule is Mohave rattlesnakes, whose neurotoxic venom requires special consideration. However, because there is little overlap between the natural range of Mohave rattlesnakes and that of the moccasins (except for the Trans-Pecos region of Texas), this is rarely a clinical dilemma.[12, 13]
If the venomousness of a particular snake is uncertain, consider taking photographs of the snake from a safe distance of at least 6 feet away using a digital or Polaroid camera.
Emergency Department Care
Adequate hydration with intravenous fluids is indicated. Patients with hypotension should be resuscitated first with 2 isotonic sodium chloride solution challenges (eg, 20 mL/kg). Treat persistent shock with colloids, followed by pressors as indicated.
Managing envenomations is a dynamic process; administer additional antivenom as indicated by a worsening clinical course. When considering the use of antivenom, the risk of allergy to antivenom must be weighed against the benefits of reducing venom toxicity. See the algorithm[14] below.
Crotaline treatment algorithm. Consultations
In the United States, the nationwide Poison Help! number, 1-800-222-1222 will connect the caller the nearest poison control center. Certified poison centers have trained personnel to assist physicians in the management of poisonings, including snake bites, with 24-hour access to medical toxicologists for specific questions.
In addition, medical toxicologists are available to provide bedside patient care at some medical centers. Medical toxicologists have specific training and expertise in snakebite management.
The manufacturer of Crotaline Fab antivenom provides a technical assistance hotline at 1-877-SERPDRUG (877-377-3784).
Consider consulting a surgeon (eg, general, orthopedic, hand) if compartment syndrome is suspected or, in the subacute phase of illness, if debridement of clearly necrotic tissue is required.
Occupational therapy, physical therapy, physiatry (rehabilitative medicine), and/or pain management consultation may be helpful to assist patients with persistent pain, swelling, or other limitations.
Wingert WA, Pattabhiraman TR, Cleland R, Meyer P, Pattabhiraman R, Russell FE. Distribution and pathology of copperhead (agkistrodon contortrix) venom. Toxicon. 1980;18(5-6):591-601. [Medline].
Sullivan JB, Wingert WA, Norris RL Jr. North American venomous reptile bites. In: PS Auerbach, ed. Wilderness Medicine: Management of Wilderness and Environmental Emergencies. Vol 2. St. Louis: Mosby-Year Book; 1995:680-709.
Thorson A, Lavonas EJ, Rouse AM, Kerns WP 2nd. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003;41(1):29-35. [Medline].
Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol (Phila). Dec 2007;45(8):815-917. [Medline].
Spiller HA, Bosse GM. Prospective study of morbidity associated with snakebite envenomation. J Toxicol Clin Toxicol. 2003;41(2):125-30. [Medline].
Bush SP, Thomas TL, et al. Envenomations in children. Pediatr Emerg Med Rep. 1997;2:1-12.
Scharman EJ, Noffsinger VD. Copperhead snakebites: clinical severity of local effects. Ann Emerg Med. Jul 2001;38(1):55-61. [Medline].
Bush SP, Hegewald KG, Green SM, Cardwell MD, Hayes WK. Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. Wilderness Environ Med. Fall 2000;11(3):180-8. [Medline].
Bush SP. Snakebite suction devices don't remove venom: they just suck. Ann Emerg Med. Feb 2004;43(2):187-8. [Medline].
Burch JM, Agarwal R, Mattox KL, Feliciano DV, Jordan GL Jr. The treatment of crotalid envenomation without antivenin. J Trauma. Jan 1988;28(1):35-43. [Medline].
Whitley RE. Conservative treatment of copperhead snakebites without antivenin. J Trauma. Aug 1996;41(2):219-21. [Medline].
Dart RC, McNally JT, Spaite DW, Gustafson R. The Sequelae of Pitviper Poisoning in the United States. In: Campbell JA, Brooks DE, editors. Biology of the Pitvipers: Tyler, TX: Selva; 2002:395-404.
Gold BS, Wingert WA. Snake venom poisoning in the United States: a review of therapeutic practice. South Med J. Jun 1994;87(6):579-89. [Medline].
Lavonas EJ, Ruha AM, Banner W, Bebarta V, Bernstein JN, Bush SP, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. Feb 3 2011;11:2. [Medline]. [Full Text].
Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. Jul 1997;30(1):33-9. [Medline].
Lawrence WT, Giannopoulos A, Hansen A. Pit viper bites: rational management in locales in which copperheads and cottonmouths predominate. Ann Plast Surg. Mar 1996;36(3):276-85. [Medline].
Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. Jun 2002;39(6):609-15. [Medline].
Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. Sep 10 2001;161(16):2030-6. [Medline].
Jurkovich GJ, Luterman A, McCullar K, et al. Complications of Crotalidae Antivenin Therapy. Journal of Trauma. 1998;28:1032-1037.
Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W Jr, et al. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. Feb 2004;43(2):200-6. [Medline].

